Fidasimtamab
Product Specifications
CAS Number
2377419-89-9
Target
PD-1/PD-L1, HER, EGFR
Related Pathways
Cell Cycle/Checkpoint, Apoptosis, Immunology/Inflammation, Angiogenesis, JAK/STAT signaling, Tyrosine Kinase/Adaptors
Purity
0.983
Bioactivity
Fidasimtamab is a recombinant human IgG1 bispecific antibody designed to target and inhibit both HER2 and PD-1 signaling pathways. Fidasimtamab bridges PD-1 expressing T cells with HER2 expressing tumor cells, thereby modulating immune responses while exhibiting potential immunosuppressive and antitumor effects. This mechanism provides an unique therapeutic approach for cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC741774-500 1x 500 µL
Chromogranin A / CHGA (Neuroendocrine Marker), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
